By Larry Quick
Seventh in a series
The previous article is available at thevoice.us/all-respiratory-viruses-follow-a-bell-shaped-pattern
COVID-19 is caused by the SARS-Cov-2 respiratory virus. Have physicians and scientists discovered effective preventative measures and affordable treatments for COVID-19? This week’s article will focus this question.
Dr. Delores Cahill, expert immunologist, states that an effective way to avoid becoming ill with COVID-19, is to strengthen one’s immune system through regularly taking vitamins C and D and the mineral supplement zinc. (21stcenturywire.com/2020/05/13/interview-debunking-the-COVID-19-narrative-with-prof-dolores-cahill). A strong immune system protects you against harmful viruses and bacteria, and is supported by adequate sleep and by avoiding unnecessary stress.
Which treatments have been shown to be safe, effective and affordable for those infected with the SARS-CoV-2 virus, but who are having difficulty recovering on their own? Thomas Levy, M.D. wrote:
“Both chloroquine and hydroxychloroquine are old drugs that are very safe at the doses shown to be effective in treating COVID-19, and they are both recognized as having significant nonspecific antiviral properties. Also, chloroquine, and probably hydroxychloroquine as well, are zinc ionophores, which is likely the reason why they have such significant antiviral properties. As noted above in the discussion on zinc, agents (such as hydroxychloroquine) that greatly facilitate zinc transport inside virus-infected cells, rapidly accelerate virus destruction and clinical resolution of the viral infection. Many clinicians now feel that chloroquine and hydroxychloroquine therapy for COVID-19 and other viruses is optimized by concomitant zinc administration. Certainly, there is no good reason to avoid taking zinc with these agents.” (orthomolecular.org/resources/omns/v16n37.shtml)
“As might be expected, drugs as potently antiviral to COVID-19 as chloroquine and hydroxychloroquine would be expected to be effective preventive agents as well, particularly in the setting where exposure is known or strongly suspected to have taken place, or in a setting where repeated and substantial exposure will reliably occur, as in COVID-19-treating hospitals. Many front-line health care workers are on such preventive protocols.” (orthomolecular.org/resources/omns/v16n37.shtml)
Dr. Harvey Risch of Yale University’s School of Public Health wrote:
“As professor of epidemiology at Yale School of Public Health, I have authored over 300 peer-reviewed publications and currently hold senior positions on the editorial boards of several leading journals. I am usually accustomed to advocating for positions within the mainstream of medicine, so have been flummoxed to find that, in the midst of a crisis, I am fighting for a treatment that the data fully support but which, for reasons having nothing to do with a correct understanding of the science, has been pushed to the sidelines. As a result, tens of thousands of patients with COVID-19 are dying unnecessarily. Fortunately, the situation can be reversed easily and quickly.
“I am referring, of course, to the medication hydroxychloroquine. When this inexpensive oral medication is given very early in the course of illness, before the virus has had time to multiply beyond control, it has shown to be highly effective, especially when given in combination with the antibiotics azithromycin or doxycycline and the nutritional supplement zinc.”
Opinion Coronavirus Health and Medicine Medicine FDA
Brian Procter, MD, is a board certified family physician practicing in McKinney, Texas. Dr. Procter provides some powerful insights and suggestions for treating COVID-19 patients and ending the COVID-19 Pandemic. He and his medical colleagues have had outstanding success in treating COVID-19 patients with hydroxychloroquine and zjnc. Below is the link to his insightful video: www.youtube.com/watch?v=4tYlaHgas7U
The Association of American Physicians & Surgeons, in support of making hydroxychloroquine available to all U.S. COVID-19 patients, recently filed a lawsuit in the U.S. Court of appeals for the Sixth Circuit. Globe Newswire writes:
TUCSON, Ariz., Aug. 11, 2020 — Monday the Association of American Physicians & Surgeons filed its Petition for Writ of Mandamus with the U.S. Court of Appeals for the Sixth Circuit on its lawsuit to end governmental interference with public access to hydroxychloroquine (HCQ). The Respondents include the Food & Drug Administration (FDA) and the Department of Health & Human Services (HHS), which have blocked access to HCQ while falsely disparaging it due to their improper political and financial motivations. (bit.ly/3myYKDs)
The lawsuit is still pending. It is important to note that Illinois physicians may prescribe hydroxychloroquine for COVID-19 patients. Governor Pritzker and the IDPH have not prohibited its use in Illinois. Next week we will review approaches that have been used to re-open our schools and universities.
Continued at thevoice.us/one-doctor-sees-little-covid-19-risk-to-those-under-18-years.